This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Vanguard MidCap Growth ETF (VOT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOT
Bet on These 3 Hot Tech Stocks Instead of NVIDIA (NVDA)
by Debdutta Sinha
We pick three technology stocks that are better buys than NVIDIA (NVDA), given its gloomy near-term prospects amid declining demand for gaming chips, supply-chain issues and restrictions on selling top AI chips to China.
The Zacks Analyst Blog Highlights Synopsys, Vishay Intertechnology, Cadence Design Systems, Pure Storage and Fortinet
by Zacks Equity Research
Synopsys, Vishay Intertechnology, Cadence Design Systems, Pure Storage and Fortinet are part of The Zacks top Analyst Blog.
5 Top-Ranked Tech Stocks With Solid Upside Potential to Buy Now
by Vasundhara Sawalka
Here we present five tech stocks - SNPS, VSH, CDNS, PSTG and FTNT - which are poised to perform well in the rest of 2022 despite a volatile market.
Synopsys (SNPS) Boosts Shareholders' Wealth With $240M ASR Deal
by Zacks Equity Research
Synopsys' (SNPS) latest stock-buyback program indicates its commitment to delivering a long-term shareholder value and reflects its confidence in the financial position and the ability to generate sufficient cash flows.
Synopsys (SNPS) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Synopsys (SNPS) could produce exceptional returns because of its solid growth attributes.
Is Trending Stock Synopsys, Inc. (SNPS) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
If You Invested $1000 in Synopsys 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Synopsys (SNPS) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Synopsys' (SNPS) Q3 results reflect benefits from solid demand for its products amid rapid adoption of Big Data, faster computation and Machine Learning.
Synopsys (SNPS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 2.94% and 2.07%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Synopsys Q3 Preview: Can The Earnings Streak Continue?
by Derek Lewis
Synopsys has exceeded the Zacks Consensus EPS Estimate in 14 consecutive quarters.
Synopsys (SNPS) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Though Synopsys' (SNPS) Q3 performance is likely to have benefited from the increasing global design activity and customer engagements, persistent supply-chain issues might have hurt the top line.
Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Smith Micro Software, Inc. (SMSI) delivered earnings and revenue surprises of 0% and 2.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Most-Watched Stock Synopsys, Inc. (SNPS) Worth Betting on Now?
by Zacks Equity Research
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
OptimizeRx Corp. (OPRX) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of -60% and 18.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $372.07, moving -0.59% from the previous trading session.
Blackbaud (BLKB) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Blackbaud (BLKB) delivered earnings and revenue surprises of 8.70% and 0.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $370.01, moving +0.68% from the previous trading session.
VeriSign (VRSN) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Verisign's (VRSN) second-quarter 2022 earnings and revenues increase year over year. However, the company tweaked its outlook due to weak macroeconomic conditions.
SONY's Q1 Earnings & Revenues Increase Y/Y, Tweaks Guidance
by Zacks Equity Research
An increase in Music, Pictures, Imaging & Sensing Solutions' segment sales boost SONY's first-quarter fiscal 2022 results.
Mercury (MRCY) Wins $8-Million Video Switching Tech Contract
by Zacks Equity Research
Mercury's (MRCY) recent contract win for designing and developing video switching technology reflects the company's commitment to enhancing the future mission needs of the aerospace industry.
Fortive (FTV) Q2 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Fortive Corporation (FTV) second-quarter earnings and revenues increase year over year due to strong customer demand across all business segments.
Plexus (PLXS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Plexus' (PLXS) third-quarter fiscal 2022 results benefit from an improving demand environment and new program ramps amid global supply chain disruptions.
PTC's Q3 Earnings & Revenues Miss Estimates, Stock Down
by Zacks Equity Research
PTC's third-quarter fiscal 2022 performance gains from momentum across its product portfolio. Unfavorable forex movement and the impact of exiting Russia due to the Ukraine war were dampeners.
Telefonica's (TEF) Q2 Earnings Down, Revenues Inch Up Y/Y
by Zacks Equity Research
Telefonica, S.A. (TEF) reports dismal second-quarter 2022 net income, plunging 95.9% year over year due to capital gains booked in previous year quarter.